These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3276529)

  • 1. Cellular and molecular aspects of neoplastic progression in the mammary gland.
    Cardiff RD
    Eur J Cancer Clin Oncol; 1988 Jan; 24(1):15-20. PubMed ID: 3276529
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncogenes and breast cancer progression.
    Callahan R
    Basic Life Sci; 1991; 57():143-53; discussion 153-6. PubMed ID: 1667570
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current theories on the nature of myoepithelial cells and their role in the morphogenesis of dyshormonal hyperplasia and breast neoplasms].
    Karelina TV
    Arkh Patol; 1982; 44(2):69-73. PubMed ID: 6280649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of cellular oncogenes in benign and malignant human breast tissue.
    Whittaker JL; Walker RA; Varley JM
    Int J Cancer; 1986 Nov; 38(5):651-5. PubMed ID: 3770994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical steps in breast carcinogenesis.
    Russo J; Calaf G; Sohi N; Tahin Q; Zhang PL; Alvarado ME; Estrada S; Russo IH
    Ann N Y Acad Sci; 1993 Nov; 698():1-20. PubMed ID: 8279746
    [No Abstract]   [Full Text] [Related]  

  • 6. [Histogenesis and oncogenes of breast cancer].
    Valladares Sánchez Y
    An R Acad Nac Med (Madr); 1988; 105(1):97-136. PubMed ID: 3044180
    [No Abstract]   [Full Text] [Related]  

  • 7. [Malignant transformation of fibroadenoma of the breast].
    Rohde E
    Zentralbl Gynakol; 1989; 111(24):1629-31. PubMed ID: 2560304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Breast cancer in young age].
    Letiagin VP; Chobanian NS
    Sov Med; 1991; (4):79-81. PubMed ID: 1871643
    [No Abstract]   [Full Text] [Related]  

  • 9. [Human oncogenes].
    Barbacid M
    Rev Clin Esp; 1986 Nov; 179(8):412-27. PubMed ID: 3550930
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene amplification and expression of the neu (c-erbB-2) sequence in human mammary carcinoma.
    Fontaine J; Tesseraux M; Klein V; Bastert G; Blin N
    Oncology; 1988; 45(5):360-3. PubMed ID: 3412743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrocystic mastopathy and risk of cancer from the viewpoint of the pathologist].
    Guski H
    Z Arztl Fortbild (Jena); 1991 Oct; 85(20):970-2. PubMed ID: 1776287
    [No Abstract]   [Full Text] [Related]  

  • 12. Microglandular adenosis with transition to breast carcinoma: a series of three cases.
    Lin L; Pathmanathan N
    Pathology; 2011 Aug; 43(5):498-503. PubMed ID: 21753716
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene signals relapse of breast, ovarian cancers.
    Marx JL
    Science; 1989 May; 244(4905):654-5. PubMed ID: 2566202
    [No Abstract]   [Full Text] [Related]  

  • 14. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
    Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA
    Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Breast cancer and oncogenes].
    Toyoshima K
    Gan No Rinsho; 1989 May; Spec No():199-203. PubMed ID: 2574753
    [No Abstract]   [Full Text] [Related]  

  • 16. High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S.
    Lavialle C; Modjtahedi N; Cassingena R; Brison O
    Oncogene; 1988 Sep; 3(3):335-9. PubMed ID: 3060796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biology of solid cancers: breast cancer as an example. Second part: gene disregulation in breast cancer].
    Bièche I; Lidereau R
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(2):142-52. PubMed ID: 8690862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogene structure, function, and expression in breast cancer.
    Yee LD; Kacinski BM; Carter D
    Semin Diagn Pathol; 1989 May; 6(2):110-25. PubMed ID: 2669069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of c-ras oncogenes by mutations and amplification.
    Sistonen L; Alitalo K
    Ann Clin Res; 1986; 18(5-6):297-303. PubMed ID: 3551775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Joint amplification of c-myc and c-Ha-ras oncogenes in human breast and thyroid cancer cells].
    Pluzhnikova GF; Serova OM; Kniazev PG; Fedorov SN; Novikov LB
    Eksp Onkol; 1987; 9(2):15-7. PubMed ID: 3034547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.